-
Entity
-
Individual
-
Location
-
Aveo Pharmaceuticals, Inc., 75 Sidney Street, Cambridge, MA
-
Summary
-
The estimated net worth of Douglas G. Cole is at least $578K dollars as of June 28, 2024. Douglas G. Cole is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $489K. Douglas G. Cole is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $88.3K.